Is treatment of feline hypertrophic cardiomyopathy based in science or faith? A survey of cardiologists and a literature search - PubMed (original) (raw)

Mark Rishniw et al. J Feline Med Surg. 2011 Jul.

Abstract

Practical relevance: Feline hypertrophic cardiomyopathy (HCM) is the most common cardiac disease of cats. Treatment of HCM is usually directed at controlling signs of congestive heart failure (CHF), preventing occurrence or recurrence of systemic thromboembolism or delaying/preventing/reversing progression of subclinical disease.

Study objective and design: Despite the laudable goals of therapy, however, little objective evidence supporting therapeutic decisions has been published. We, therefore, hypothesized that cardiologists base their treatment strategies on information other than published clinically relevant science. To gain insight into therapeutic decisions that cardiologists and clinicians with an interest in cardiology (n=99) make for cats with HCM, and on what information they base these decisions, we presented participants with, and asked them to select therapy for, 12 hypothetical scenarios of HCM (± CHF). Responses and justifications for treatment choices were compiled and compared with the results of a comprehensive literature search for published information about treatment of feline HCM.

Findings: Evaluation of the therapeutic strategies chosen for these hypothetical cases of HCM suggests that cardiologists or clinicians with a strong interest in cardiology often prescribe treatments knowing that little documented evidence supports their decisions.

Copyright © 2011 ISFM and AAFP. Published by Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Figures

FIG 1

FIG 1

(a) Intent to alter primary disease progression or to treat congestive heart failure (CHF). Collated responses were restricted to drugs or interventions that are not obviously antithrombotic or anticoagulant. (b) Intent to reduce risk of occurrence of aortic thromboembolism (ATE). Collated responses were restricted to clopidogrel, aspirin, low molecular weight heparin (LMWH) and heparin. In (a) and (b) cardiologist respondents are represented by the pink bars, non-cardiologist respondents by the black bars. (c) Use of clopidogrel or LMWH

FIG 2

FIG 2

(a) Number of different treatment combinations adopted by respondents for each scenario. (b) Percentage of respondents prescribing three or more medications to patients with each scenario. CHF = congestive heart failure

FIG 3

FIG 3

Cardiologist respondents are represented by the pink bars, non-cardiologist respondents by the black bars. Numbers above bars represent the left ventricular outflow tract (LVOT) velocity (expressed in m/s) associated with LVOT obstruction presented in that particular scenario. CHF = congestive heart failure

FIG 4

FIG 4

(a) Angiotensin-converting enzyme inhibitor (ACEI) use increases with increasing severity of hypertrophic cardiomyopathy (HCM). (b) Diltiazem use is substantially lower than ACEI use and is inversely correlated with β-blocker use. Cardiologist respondents are represented by the pink bars, non-cardiologist respondents by the black bars

Comment in

Similar articles

Cited by

References

    1. . Liu SK, Tilley LP, Lord PF. Feline cardiomyopathy. Recent Adv Stud Cardiac Struct Metab 1975; 10: 627–40. - PubMed
    1. . Paige CF, Abbott JA, Elvinger F, Pyle RL. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc 2009; 234: 1398–403. - PubMed
    1. . Coté E, Manning AM, Emerson D, Laste NJ, Malakoff RL, Harpster NK. Assessment of the prevalence of heart murmurs in overtly healthy cats. J Am Vet Med Assoc 2004; 225: 384–88. - PubMed
    1. . Rush JE, Freeman LM, Fenollosa NK, Brown DJ. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999). J Am Vet Med Assoc 2002; 220: 202–7. - PubMed
    1. . Atkins CE, Gallo AM, Kurzman ID, Cowen P. Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985–1989). J Am Vet Med Assoc 1992; 201: 613–18. - PubMed

MeSH terms

LinkOut - more resources